GSA CAPITAL PARTNERS LLP - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2022$38,000
-93.5%
22,486
-67.6%
0.01%
-91.7%
Q3 2021$586,000
-34.0%
69,299
-4.9%
0.06%
-40.0%
Q2 2021$888,000
+72.8%
72,846
+243.6%
0.10%
+17.6%
Q1 2021$514,00021,2000.08%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,014,858$17,046,0000.60%
NEA Management Company, LLC 3,449,845$29,186,0000.35%
MPM BioImpact LLC 248,506$2,102,0000.33%
Artal Group S.A. 1,646,517$13,930,0000.31%
RA Capital Management 2,589,904$21,911,0000.30%
Bellevue Group AG 3,463,000$29,297,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 760,128$6,431,0000.13%
Ikarian Capital, LLC 150,484$1,272,0000.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 44,000$371,0000.09%
Virtus ETF Advisers LLC 16,600$140,0000.06%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders